FDA approves first non-invasive DNA test for colorectal cancer

Big news in the colorectal cancer prevention and screening community yesterday! In a never-before-seen move, the Food & Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly proposed Cologuard as a new option for colorectal cancer screening. What is Cologuard? Cologuard, produced by Exact Sciences, is a non-invasive (not requiring insertion of instruments…  Read More

Should Pink October Turn Blue?

By Chris Adams, Research Advocate for Fight Colorectal Cancer Last month, you may have noticed the pink jetliners, pink NFL players and pink garbage trucks.  Yes, it was Pink October, also known as National Breast Cancer Awareness Month (NBCAM).  NBCAM is probably the biggest and most successful public awareness campaign in modern US history.  NBCAM’s goal…  Read More

Wanted: 100 U.S. Representatives

H.R. 4120 has 37 cosponsors, but your help is needed to push the number to 100 by the end of September. Colorectal cancer screening is covered under Medicare without cost sharing (or co-pay), but if a Medicare patient undergoes a screening colonoscopy during which a polyp or other tissue is removed, that patient is required to…  Read More

Fighting Colorectal Cancer on Many Fronts

Indran Krishnan, MD, FRCP (London), FRCP(C), FACP, FACG is fighting colorectal cancer on many fronts. As a gastroenterologist, he personally screens people every week. As an associate professor at Emory University, he trains the next generation of physicians. As an advocate, he serves on Fight Colorectal Cancer’s Board of Directors, and was a founding member of…  Read More

Giving Patients a Screening Choice Matters

When patients  were offered a choice of colorectal cancer screening with either FOBT or colonoscopy, they were significantly more likely to complete that screening than when their doctors recommended only FOBT or only colonoscopy. Nearly 1000 racially and ethnically diverse patients in urban primary care practices were randomly assigned to get colorectal cancer screening via: Fecal occult…  Read More

Improved CRC screening results, challenges to reach Alaska Natives

Alaska Native Americans have a much higher rate of both colorectal cancer and resulting deaths than other populations—about twice those of the U.S. white population (age-adjusted) for the period of 2004 to 2008. They also have the highest rate of CRC cases of all Native American groups—nearly five times higher than American Indians living in the…  Read More